Quillivant XR 25 MG/5 ML susp 180ML
Ended Awarded
- Contract number
- SPE2DB25FWZ04
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,016
Award facts
- Contract value 100% obligated
- $3,016.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a ceiling value of $3,016.29. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains significant contract relationships with the DLA for pharmaceutical supply across multiple therapeutic categories.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and other medical supplies to support military healthcare programs worldwide. The IDC supports multiple government customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a primary vendor in the DLA's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FWZ04?
SPE2DB25FWZ04 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FWZ04 worth?
The government has obligated $3,016 on SPE2DB25FWZ04.
Is contract SPE2DB25FWZ04 an order under another contract?
Yes. SPE2DB25FWZ04 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWZ04 competed?
The extent of competition for SPE2DB25FWZ04 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award